Sabinsa Corporation Completed 22 Years in Research, Marketing and Manufacturing


2015 :

  • Sabinsa’s LactoSpore® Human Safety Study Cleared for Health Canada Access.
  • Sabinsa Patent Infringement Litigation Against Prakruti Settled: Curcumin C3 Complex® Patent Successfully Defended.
  • Sabinsa Launches New, Nano-Free Water Soluble Curcumin Form: uC3 Clear™.
  • Sami Labs Recognized With Two State Export Excellence Awards By Visvesvaraya Trade Promotion Centre, Karnataka, India.
  • Sabinsa Once More Successfully Protects Curcumin C3 Complex® Patent Infringement Litigation Against Herbakraft Settled.
  • Sabinsa Awarded Four New Us Patents: Patent Portfolio Total Climbs To 95.
  • Sabinsa Expands Herb Cultivation Program Founder Promotes Sustainability, Advocates Cultivation To Protect India’s Herbal Legacy.
  • Sabinsa’s Curcumin C3 Complex® Shows Significant Benefits In Lipid Levels In Patients With Coronary Artery Disease.
  • UK Study Shows Sabinsa’s Curcumin® C3 Complex To Be Safe Adjunct To, And Enhance Efficacy Of, Folfox Chemotherapy.
  • Sabinsa / Sami Labs Recognized With Award For Export Excellence By Karnataka Chamber Of Commerce.
  • Sabinsa’s Utah Facility Receives Foreign Site Registration Number From Canada.
  • Shaheen Majeed Appointed To Sami Labs Group Board of Directors.
  • Sabinsa Again Honored With Two Pharmexcil Awards Noting Excellence In Patents And Exports.
  • Curry Powder To Clinical Significance: New Book Provides a Comprehensive Understanding of Curcumin & Studies on Curcumin C3 Complex®.
  • Sabinsa Victorious In Litigation Against Nutribiolink For Curcumin C3 Complex® Patent Infringement.

2014 :

  • Sabinsa adds four new patents, bringing world wide portfolio to 91.
  • C3 Reduct® wins Functional ingredients editors’ choice award for best science.
  • Sami and Sabinsa receive Best New Product Excellence Award in the Raw Material category at Panacea-Natural Product Expo India for Saberry®.
  • Sabinsa / Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS).
  • Sabinsa / Sami Labs receives two Pharmexcil Awards for 2012 – 2013 in the Herbals, Ayurveda & Nutraceuticals category: the Gold Award for Patents and the Silver Award for Exports in Herbals.
  • Former President of India visits Sami Labs (late A.P.J. Abdul Kalam).
  • Sabinsa Introduces new form of coleus with ForsLean® Soft Extract.
  • Study shows Boswellia® cream may provide relief for psoriasis.
  • Sabinsa initiates lawsuit against four companies for C3 Complex® patent infringement.
  • Iranian clinical study shows combination of C3 Complex® and BioPerine® offer relief for osteoarthritis patients.
  • Sabinsa launches animal nutrition division: VetVitals®.
  • Sabinsa’s C3 Complex® shown in study to benefit metabolic syndrome.
  • Sabinsa/Sami Labs acquires KCP Biotech, expands capacity and adds more colors.
  • Sabinsa teams up with Fruit D’Or to launch LactoSpore®-Cranberry combination LactoCran.
  • Sabinsa’s LactoSpore® moves into cosmeceuticals with topical Candida products.

2013 :

  • Next Generation of Curcumin Launched, Resolving Potency, Color, Dosage, Stability and Bioavailability Concerns, called Curcumin C3 Reduct®
  • Recipient of Frost & Sullivan’s 2013 North American Integrated Prebiotic Delivery Technology Innovation Award
  • United States Patent Granted On A Unique Weight Management Formula
  • United States Patent Granted For A Natural Preservative, SabiLize®
  • Sabinsa Utah Facility Earns NSF Good Manufacturing Practices (GMP) Registration
  • Sabinsa on Wheels Returns to USA, Three Major States Selected and Presented At Utah, California, and New Jersey
  • Sabinsa’s Curcumin Receives GRAS No Comment Letter From FDA
  • Sabinsa's Sami Labs Named Product Innovator Of The Year
  • Sabinsa's LactoSpore® Inspires Gluten-Free Expert To Create Gourmet Cookies
  • Sabinsa Launches D'Cosmix Range Of Dermaceutical Composites At International Exhibitions
  • Sabinsa Breaks Ground On Additional Facility, Increasing Production 200%

2012 :

  • Curcumin C3 Complex® Wins Functional Ingredients Editor's Choice Award in the Marketing Category
  • LactoSpore® Chosen For Tutti Frutti, World's Top Selling Self-Serve Frozen Yogurt
  • The first non-diary use of Sabinsa’s Shelf-Stable Probiotic, LactoSpore®, can be found in Colombia’s Perman Bread
  • New Study Says Sabinsa's Curcumin C3 Complex® Shows Significant Reduction In Serum Triglycerides
  • Sabinsa Publishes Book On Tetrahydrocurcuminoids
  • Sabinsa On Wheels Held for the First Time in Seoul, South Korea
  • Sabinsa Wins Patent In Japan For Coleus Derived Glaucoma Treatment Product

2011 :

  • Sabinsa Introduces Integrated Nutritional Composites
  • Sabinsa's BioPerine® Validated in Resveratrol Pre-Clinical Study
  • Sabinsa Opens Office in South Korea
  • Sabinsa Receives Top Pharmexcil Award
  • Sabinsa R&D Named Best Innovation and Technology Company by FICCI

2010 :

  • Sami's Kunigal plant near Bangalore India received NSF (National Sanitation Foundation) GMP Certification
  • Received the first Patent in China for "Process For Preparing Water Soluble Diterpenes And Their Applications"
  • Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian Market
  • Sami's Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification

2009 :

  • Sabinsa received the 2009 Herbal Industry Leader Award from the American Herbal Products Association.
  • Sabinsa received its 57th patent and it is the First patent from Russia.

2008 :

  • NABL accreditation for Laboratories of Sami Labs Limited.
  • Continuous Extraction plant commissioned by Sami Labs Limited in Bangalore.

2007 :

  • Sabinsa sets up its office in South Africa.

2006 :

  • Forskolin Eye Drops approved by DCGI for Glaucoma.
  • Sabinsa Europe GmBH was set up in Langen, near Frankfurt in Germany.

2005 :

  • Received two patents for Tetrahydropiperine.
  • Received the second Thomas Alva Edison Patent Award for 2005.

2004 :

  • Sabinsa's US Patent for ForsLean® received the Thomas Alva Edison Patent Award for 2004.
  • Dr. Majeed was conferred the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations (NECO).

2003 :

  • MGP Herbal (P) Ltd was acquired to facilitate and co-ordinate Herbal Cultivation - a major step that helped provide jobs to several farmers in India.

2002 :

  • Super-Critical Fluid Extraction facility set up at Nelamangala.
  • The R & D Centre of Sami Labs Limited, Bangalore received the DSIR Award for its R & D efforts.

2001 :

  • The anti-obesity product Forslean® was voted as the Best New Product of the year by Nutraceutical Industry Association – Nutracon in the US.
  • Sabinsa received its first European patent on Curcuminoids.
  • Sabinsa Japan Corporation was started.

2000 :

  • Biotechnology Center established at Nelamangala, Bangalore.
  • Tetrahydrocurcuminoids, also referred to as “White Curcumin” was introduced as a skin lightener into the US market.

1998 :

  • Sami Chemicals and Extract Pvt. Ltd. – name was changed to Sami Labs Limited to reflect more accurately its current activities.

1997 :

  • New Jersey Technology Fast 50 Award.
  • Sabinsa listed again in the Inc 500 companies, ranking # 90.
  • Award for Export Performance for Spice products from President of India.

1996 :

  • Sabinsa was listed in the Inc 500 companies, ranking # 70.
  • First US patent awarded for the product Bioperine® was awarded to Sabinsa Corporation.
  • An Export-Oriented manufacturing unit is established at Kunigal, Bangalore.

1993-95 :

  • Standardization of Indian herbal medicines by Sami research group.
  • Sabinsa started the “Sabinsa on Wheels” program also know as SOW. Here the Sabinsa team endeavors to share its knowledge to a large group of professionals and common man on its diverse range of products.

1991 :

  • Sami Chemicals and Extracts Pvt Ltd set up in Bangalore.

1988 :

  • Sabinsa Corporation, New Jersey USA was setup.